Our Companies

We develop companies with disciplined, targeted strategies that address specific clinical areas. 

 
 
Paragon-BioSci-CastleCreek-Logo.png
jeffrey-aronin-castle-creek-pharma-paragon.jpg

castle creek

Castle Creek Pharma employs a unique strategy that has made us one of the industry’s most prolific developers of innovative and high potential late stage assets for dermatological and ENT therapies identified as having the greatest medical need.

Paragon-BioSci-Harmony-Logo.png
jeffrey-aronin-harmony-biosciences-paragon.jpg

harmony

Harmony Biosciences is a biopharmaceutical company focused on identifying, developing, obtaining regulatory approval, and commercializing high-potential, innovative drugs to address unmet needs for patients with sleep and central nervous system (CNS) disorders.

Paragon-BioSci-PrecisionBP-Logo.png
jeffrey-aronin-liffey-vax-paragon.jpg

Precision BP

Precision is a research and development driven organization focused on developing complex treatments in rare genetic oncology diseases.

Paragon-BioSci-Decade-Logo.png
jeffrey-aronin-decade-pharmaceuticals-llc-paragon.jpg

DECADE

Decade is a research and development company focused on novel Alzheimer’s disease therapeutics that will fundamentally improve patient outcomes and quality of life.